ranitidine 150mg tablets
ennogen pharma ltd - ranitidine hydrochloride - oral tablet - 150mg
ranitidine 150mg tablets
milpharm ltd - ranitidine hydrochloride - oral tablet - 150mg
ranitidine 300mg tablets
milpharm ltd - ranitidine hydrochloride - oral tablet - 300mg
sentradine- ranitidine hydrochloride, choline kit
physician therapeutics llc - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine hydrochloride 150 mg - ranitidine tablets, usp is indicated in: 1. short-term treatment of active duodenal ulcer. most patients heal within 4 weeks. studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. 2. maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. no placebo-controlled comparative studies have been carried out for periods of longer than 1 year. 3. the treatment of pathological hypersecretory conditions (e.g., zollinger-ellison syndrome and systemic mastocytosis). 4. short-term treatment of active, benign gastric ulcer. most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. 5. maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. placebo-controlled studies have b
ranitidine 75mg tablets
galpharm international ltd - ranitidine hydrochloride - oral tablet - 75mg
ranitidine 75mg tablets
nucare plc - ranitidine hydrochloride - oral tablet - 75mg
ranitidine 75mg tablets
vantage - ranitidine hydrochloride - oral tablet - 75mg
ranitidine 75mg tablets
sigma pharmaceuticals plc - ranitidine hydrochloride - oral tablet - 75mg
ranitidine 75mg tablets
cubic pharmaceuticals ltd - ranitidine hydrochloride - oral tablet - 75mg
ranitidine 75mg tablets
medrx developments ltd - ranitidine hydrochloride - oral tablet - 75mg